TSG101 and breast cancer: Similar to the reported posttranslational downregulation of the ESCRT-1 binding partner VPS28 in siRNA-mediated TSG101 knockdown cell lines [50, 51], we observed a concomitant upregulation of VPS28 in mammary tumors with high overexpression of TSG101.